Market Review: October 12, 2026

Closing Recap

Monday, October 12, 2026

Much ado about nothing summed up today’s stock market action as technology stocks (XLK) lagged all day behind a pullback in semiconductors (SOX -2.7%), though nine of the eleven S&P sectors finished higher, led by Energy (XLE +1.43%) and Communications (XLC +0.97%) as the S&P 500 finished flattish and in a tight trading range all day. Today was Columbus Day with banks and the bond market closed, while stocks markets felt like they were closed, awaiting key economic data and earnings this week. The consumer price index (CPI) on Wednesday morning is the big inflation data point as the Street is looking for headline inflation to re-accelerate to 3.6% and core to reach 2.5%. Beige Book follows Wednesday afternoon, with PPI on deck Thursday morning. Bank earnings kick off in size: JPM, GS, C, WFC, BAC, MS, BLK, SCHW and the rest of the financial complex should give the first real read on the economy, credit trends and market activity. Tomorrow we get JNJ and UNH in the healthcare sector and JPM, WFC, GS, Citi in banks.

• U.S. WTI crude oil futures settle at $93.74/bbl, up $1.89, or 2.06%, while Brent Crude futures settle at $106.65/bbl, up $1.93, or 1.84%. Oil rose as attacks on Saudi Arabia’s airports outweighed prospects of increased supply from fresh Russian diesel exports and a Russia-Ukraine energy ceasefire. Cleveland Fed President Beth Hammack said the Fed should move "relatively quickly" to a restrictive stance as inflation becomes more broad-based and impacts firms’ pricing decisions. Ukrainian President Volodymyr Zelenskiy said it was increasingly clear Russia would not accept a US-proposed ceasefire on energy strikes after attacks on six Ukrainian energy facilities.

• Luxury Retail: LVMUY reported worse-than-expected Q3 organic sales growth as weak demand for its Fashion and Leather goods weighed. Organic sales, which strip out currency swings, rose 1% Y/y to €18.28B ($20.40B), compared with the 1.3% increase expected. The Fashion and Leather goods division posted a -5% fall in organic sales, against an expected -1.8% decline.
• Auto Sector: STLA unveiled six concept vehicles Sunday ahead of the Paris Motor Show, highlighting the automaker’s efforts to revive its brands and attract budget-conscious buyers. VWAGY said deliveries fell in the third quarter as the German automaker continued to suffer from a deteriorating market in China. Chinese Ev stocks (NIO, LI, XPEV) were pressured after Bloomberg reported the European Union will instill a 350,000-car limit per year for imports of Chinese hybrid vehicles, with the measure taking effect as soon as December 1.

• Refining sector: shares of DINO, DK, PBF, PSX, MPC, VLO among refining names that have surged in 2026, and gained ~4% on average last week in what was an eventful period. Piper noted refiners saw an executive order signed to defer certain taxes on red dyed diesel, a deal struck with Russia to supply additional diesel onto the global/US market, and a Category 2 hurricane making landfall on the Gulf Coast but missing the key Gc refining complex. While Piper is not surprised to see more moves targeted towards lowering diesel prices ahead of mid- term elections, it does not expect a meaningful near or long term impact to the fundamental story as a result of these developments.

• Insurance sector: ALL was upgraded to Equal Weight from Underweight at Wells Fargo following recent underperformance noting the shares have significantly underperformed since the start of September in part due to the Muse rollout at the start of the month. BRO upgraded to Outperform from Market Perform at KBW Inc. in insurance brokers, since easier prior-period comparables should support improving organic growth even as small-account and middle market P&C pricing slowly decelerates. Also, KBW downgrades BWIN to Market Perform with the stock near its recently announced pending take-private acquisition price.
• Lending sector: SLM was upgraded to Overweight at Morgan Stanley calling it an attractive entry point ahead of capital-light trajectory; nots with shares lower amid macro/credit concerns, sees an improving setup and a second capital-light partnership is the next key catalyst. ALLY was downgraded to Equal Weight at Morgan Stanley saying higher rates drive a reset to 2027/28 expectations and flatter NIM & credit losses no longer improving mean the path to a mid-teens ROTCE takes longer. Mizuho downgrades FNMA and FMCC to Neutral from Outperform (FNMA PT to $5 from $10; FMCC PT to $4 from $9), based on a lower likelihood of a privatization by 2028.

• BIIB was upgraded to Overweight from Neutral at JP Morgan ahead of an increasingly compelling catalyst path and an improved long-term growth outlook for the company.
• BMY said its experimental drug met the main goal of a late-stage trial in patients with idiopathic pulmonary fibrosis, a serious lung-scarring disease.
• CORT is seeking to exclude testimony from a retired federal appeals court judge supporting TEVA in an antitrust lawsuit, arguing her opinions could sway jurors without shedding Light on the facts of the case. In a filing on Friday in federal court in California, Corcept said consultant and retired judge Kathleen O’Malley of the US Court of Appeals for the Federal Circuit offered no technical expertise and that her presentation of legal opinions was inappropriate – Reuters
• CTNM shares fell after BMY’s admilparant meets the main goal of a late-stage trial in idiopathic pulmonary fibrosis at the 60 mg dose, but the 120 mg dose did not reach statistical significance. If approved, admilparant would become the first in a class of medicines called LPA1 inhibitors to treat IPF (Contineum is testing once-daily PIPE-791, which targets the same LPA1 pathway as twice-daily admilparant, in patients with IPF, a serious lung-scarring disease).
• HRMY announces planned CEO transition to support next phase of growth; appoints Peter Anastasiou as President, CEO, and board member effective Jan 1, 2027, as Jeffrey M. Dayno to retire as CEO and step down from board at year-end 2026.
• MRK said its experimental eye drug remigromig improved vision in patients with a diabetes-related eye disease, meeting the main goal of a late-stage clinical trial. However, patients receiving the treatment experienced higher rates of a potentially serious eye complication than those taking an established medication.
• RGNX sets Oct. 20 Investor Event on Sura-vec ahead of Q4 2026 Pivotal Wet AMD Data; Event will review the sura-vec (ABBV-RGX-314) clinical program, including the ATMOSPHERE and ASCENT pivotal trials.
• STE expands Healthcare consumables offering with definitive agreement to acquire Xodus Medical, a Specialty Surgical products business focused on patient and or staff safety for $2.10B at closing; expects net purchase price of $1.80B after $300M cash tax benefits.
• TRAX announces positive top-line results for its drug, ANB033, in gluten-challenge study in celiac disease; ANB033 is co’s experimental antibody drug to treat autoimmune and inflammatory diseases, including celiac disease

• Satellite and telco sector: ASTS was upgraded to Buy from Hold at Deutsche Bank with an unchanged price target of $93 saying with the stock down about 65% from its all-time high seen this past May, the firm sees an opportune time to become more constructive given both recent weakness and a number of positive developments that have gone under the radar. TMUS was upgraded from Market Perform to Outperform at Raymond James ahead of results saying believes the recent fears over competition form SpaceX are overblown, as they are 3+ years away from becoming reality, and competition from larger players is nothing new to T Mobile.
• Aerospace & Defense sector: Goldman Sachs previewed the sector saying they favor HII (on CL), WWD, TDG, ARXS, AVEX and are cautious on LMT, BAH, MRCY. They see High-Bandwidth Flash (HBF) and other high-performance NAND solutions as a promising answer to AI inference memory bottlenecks, and estimate a $40-$150B TAM by 2030, with HBF potentially lowering inference throughput cost by roughly 30% through better GPU utilization. While adoption remains early and technically challenging, we think HBF could extend tight NAND fundamentals.

• AI sector: AMZN is in talks to acquire artificial-intelligence startup Decart in a deal that could be valued at around $7 billion, the WSJ reported citing people familiar with the matter. Decart’s software makes it easier for developers to switch between different AI chips. META shares rise as CEO Zuckerberg hints Meta’s strongest model Watermelon is coming soon.
• Cable sector: CABO provides update on the pending purchase of Mega Broadband; U.S. court issues TRO prohibiting Cable One from acquiring 55% of MBI on October 9th; CABO makes substantial progress toward financing transactions with GTCR and lenders; transactions expected to extend and reduce revolving credit facility, pay down b-4 term loan.
• Quantum sector: IONQ to acquire Elisity to accelerate zero Trust for the Quantum Era in all-stock deal valued up to $1.3B. The deal value includes up to $150 million in earn-outs tied to Elisity’s performance; share price for deal capped at $49.61, floor at $33.07 per share.
• Media sector: BMBL shares jumped after the WSJ reported the dating app is in advanced talks to be taken private in a deal that values it at roughly $1B, according to people familiar with the matter. The buyer is Ithaca Holdings, a firm founded recently by two Silicon Valley executives.

• ADBE was downgraded to Underweight at Wells Fargo saying Q3 results were fairly muted and suggestive that more meaningful cracks are now starting to show in the Adobe growth profile.
• CCC shares jumped after Bloomberg reported Private equity firm GTCR and activist investor Elliott Mgmt are in advanced talks to acquire the software provider https://tinyurl.com/3bhukz7k
• CRM was upgraded to Buy from Underperform at Banc America and raised the tgt to $285 from $160 saying prior concern was centered on AI-driven disintermediation, but conversations with CIOs and other market participants suggest that large enterprises are unlikely to replace platforms that house their business logic, data, workflows and compliance frameworks.
• HUBS was downgraded from Overweight to Equal Weight at Barclays with $240 tgt as its original thesis was centered on the belief that Ai usage would drive a growth acceleration by unlocking incremental wallet share through credits-based monetization. While remains constructive on that long-term opportunity, it now believes the timing will take longer than expected.
• MANH was upgraded to Overweight at Morgan Stanley saying Cloud bookings have accelerated to 30%+, while 2H Cloud revenue guidance looks conservative, setting up estimate upside to consensus’ 20% Cloud growth in FY27.  
• MNDY was downgraded to Equal Weight from Overweight at Barclay’s with an unchanged price target of $100 saying believes the company’s AI monetization story is gaining traction but remains in the early innings and is not enough to offset a deceleration in Monday.com’s core growth.

• Memory and HDD stocks MU, SNDK, WDC, STX weaker after reports that CXMT is making progress on a new memory chip architecture designed to increase storage density, raising incremental competitive concerns around the memory landscape.  https://tinyurl.com/ykr3hstw
• Anthropic is still the main event Wednesday, when some investors gather at its San Francisco headquarters.
• ASML will raise the price of spare Parts for DUV and EUV Tools by 10% from January 2027 onwards, according to reports.
• CRUS had offered to acquire SYNA in September, as the semiconductor company looked to fend off a competing bid from ON, Bloomberg reported, citing people familiar with the matter. The report came after onsemi agreed to acquire Synaptics for $123 per share in an all-cash deal worth roughly $5.7B last week, revising its previous all-stock bid worth about $7B disclosed in June.
• NVDA in talks to acquire Frontier open-weight LLM developer Reflection Ai in a deal that could exceed $25B, potentially deepening its competition with major foundation model providers – Financial Times reported this weekend.
• TTMI announces $400M investment plan in China and Malaysia; expansion initiative represents incremental investments to the previously disclosed commitment to invest $1.2B through the 2025-2029 timeframe.